Turner Syndrome
Turner
syndrome (TS), also known 45,X, or 45,X0, may be a genetic condition during which a female is partly or completely missing an X
chromosome . Signs and symptoms vary among those affected. Often, a brief and webbed neck, low-set ears, low hairline at the rear of the neck, short stature, and swollen hands and feet are seen at birth. Typically, they develop menstrual periods and breasts only with
hormone treatment, and are unable to possess children without reproductive technology. Heart defects, diabetes, and low
hormone occur more frequently. most of the people with TS have normal intelligence. Many have troubles with spatial visualization which will be needed for mathematics. Vision and hearing problems occur more often. Turner
syndrome isn't usually inherited; rather, it occurs as results of a genetic disease arising during formation of the reproductive
cells during a parent or in early cellular division during development. No
environmental risks are known, and therefore the mother's age doesn't play a task . Turner
syndrome is thanks to a chromosomal abnormality during which all or a part of one among the X
chromosomes is missing or altered. While most of the people have 46 chromosomes, people with TS usually have 45. The chromosomal abnormality could also be present in only some
cells during which case it's referred to as TS with mosaicism. In these cases, the symptoms are usually fewer and possibly none occur in the least. Diagnosis is predicated on physical signs and genetic testing.
High Impact List of Articles
-
Weight loss and diabetes are new risk factor for the development of invasive aspergillosis infection in non-immunocompromized
humans
Farhad Ghanaat & John A Tayek*
Research Article: Clinical Practice
-
Weight loss and diabetes are new risk factor for the development of invasive aspergillosis infection in non-immunocompromized
humans
Farhad Ghanaat & John A Tayek*
Research Article: Clinical Practice
-
Why age (and timing) really matters in developing drugs for neurodegenerative disease
Dave Morgan and Amanda G Smith
Editorial: Clinical Practice
-
Why age (and timing) really matters in developing drugs for neurodegenerative disease
Dave Morgan and Amanda G Smith
Editorial: Clinical Practice
-
Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation
Jaspal S Taggar, Gregory YH Lip, Aravinda Nanjundappa, Robert S Dieter, Sangeeta Mandapaka, Pranab Das and Shakeel Ahmad
Research Highlights: Clinical Practice
-
Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation
Jaspal S Taggar, Gregory YH Lip, Aravinda Nanjundappa, Robert S Dieter, Sangeeta Mandapaka, Pranab Das and Shakeel Ahmad
Research Highlights: Clinical Practice
-
New directions in endocrine therapy: renewed interest in the androgen receptor
Zoran Culig and Alfred Hobisch
Review Article: Clinical Practice
-
New directions in endocrine therapy: renewed interest in the androgen receptor
Zoran Culig and Alfred Hobisch
Review Article: Clinical Practice
-
Roflumilast: a novel phosphodiesterase 4 inhibitor for the treatment of inflammatory airways disease
Victoria Boswell-Smith and Clive P Page
Drug Evaluation: Clinical Practice
-
Roflumilast: a novel phosphodiesterase 4 inhibitor for the treatment of inflammatory airways disease
Victoria Boswell-Smith and Clive P Page
Drug Evaluation: Clinical Practice
-
Sustained-release bupropion in the treatment of SSRI nonresponder pathologic gamblers: pilot study and review of the literature
Pinhas N Dannon, Katherine Lowengrub, Ernest Musin, Yehudit Gonopolski and Moshe Kotler
Research Article: Clinical Practice
-
Sustained-release bupropion in the treatment of SSRI nonresponder pathologic gamblers: pilot study and review of the literature
Pinhas N Dannon, Katherine Lowengrub, Ernest Musin, Yehudit Gonopolski and Moshe Kotler
Research Article: Clinical Practice
Relevant Topics in Clinical